ReviewTouchREVIEWS in endocrinology2022

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium-Glucose Co-transporter-2 Inhibitors.

Joshua J Neumiller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.